EUVIMEDEUVIMED entdecken
Multizentrische Studie

Clinical Features and Outcomes of Human Herpesvirus-6 DNAemia in Critically Ill Patients: A Retrospective Multicenter Analysis

Margot Combet iD, Agnès Gautheret-Dejean, Charles-Edouard Luyt iD, Nicolas Weiss, Julien Mayaux, Marie Lecronier iD, Charlotte Calligaris iD, Sophie Demeret, Nicolas Gauthier iD, Martin Dres, Marc Pineton de Chambrun, Valérie Pourcher iD und 3 weitere

Clinical Infectious Diseases · 30.04.2026 · 82 (4) · 698-708

DOI: 10.1093/cid/ciaf199 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 18.04.2025. Verfasst von Margot Combet und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department R3S, Service de Médecine Intensive-Réanimation, APHP Sorbonne Université, Site Pitié-Salpêtrière, Paris, France. Hauptthemen laut MEDLINE: Herpesvirus 6, Human, Critical Illness, DNA, Viral, Roseolovirus Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human herpesvirus-6 (HHV-6) DNAemia is not rare in intensive care unit (ICU) patients. However, evidence for a causal association of HHV-6 DNAemia with organ disease and with mortality is limited in this setting. In ICU patients with HHV-6 DNAemia, we sought to (1) assess the prevalence of HHV-6 disease, (2) identify risk factors for HHV-6 disease, and (3) investigate its association with mortality.

Methods

This was a retrospective multicenter case-matched study in 3 ICUs from January 2011 to January 2022 of patients with HHV-6 viral load in whole blood (genome equivalent copies/106 cells) detected during the ICU stay.

Results

A total of 168 patients were included. Seventeen (10%) were classified as having HHV-6 disease (ie, HHV-6 DNAemia with attributable end-organ disease) and 151 (90%) as HHV-6 reactivation (ie, HHV-6 DNAemia without any attributable end-organ disease). Immunosuppression was significantly more frequent in patients with HHV-6 (100% vs 48%; P < .001). Eleven (65%) patients with HHV-6 disease received hematopoietic stem cell transplantation (HSCT). End-organ diseases were encephalitis (n = 10) and pneumonia (n = 7). ICU mortality was 32% (n = 53). In multivariate analysis, HHV-6 disease remained independently associated with ICU (odds ratio [OR]: 4.90) and 90-day (hazard ratio: 2.25) mortality. Mortality remained significantly higher in the HHV-6 disease group (OR: 4.30) compared with matched ICU patients without HHV-6 DNAemia.

Conclusions

Our analysis suggests that HHV-6 disease develops in 10% of patients with HHV-6 detection in the ICU, mostly in the setting of allogeneic HSCT, and is independently associated with ICU and 90-day mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 6, HumanCritical IllnessDNA, ViralRoseolovirus InfectionsViremiaHumansRetrospective StudiesMaleFemaleMiddle AgedIntensive Care UnitsAgedRisk FactorsViral LoadCase-Control StudiesAdultPrevalence

Stichwörter der Autor:innen

encephalitishematopoietic stem cell transplanthuman herpesvirus-6idiopathic pneumonia syndromeintensive care unit

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department R3S, Service de Médecine Intensive-Réanimation, APHP Sorbonne Université, Site Pitié-Salpêtrière, Paris, France.
  • UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Université, INSERM, Paris, France.
  • Université Paris Cité, INSERM UMR-S 1139, 3PHM, Paris, France.
  • Service de Virologie, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière Charles Foix, Paris, France.
  • Faculté de Pharmacie, Laboratoire de Microbiologie, Université Paris Cité, Paris, France.
  • Service de Médecine Intensive Réanimation, Institut de Cardiologie, APHP Sorbonne Université, Site Pitié-Salpêtrière, Paris, France.

ORCID-Profile: Margot Combet, Charles-Edouard Luyt, Marie Lecronier, Charlotte Calligaris, Nicolas Gauthier, Valérie Pourcher, Maxens Decavèle

Zitieren

APA

Combet, M., Gautheret-Dejean, A., Luyt, C. E., Weiss, N., Mayaux, J., Lecronier, M., Calligaris, C., Demeret, S., Gauthier, N., Dres, M., Pineton de Chambrun, M., Pourcher, V., Chommeloux, J., Demoule, A., & Decavèle, M. (2026). Clinical Features and Outcomes of Human Herpesvirus-6 DNAemia in Critically Ill Patients: A Retrospective Multicenter Analysis. Clinical Infectious Diseases, 82(4), 698-708. https://doi.org/10.1093/cid/ciaf199

Vancouver

Combet M, Gautheret-Dejean A, Luyt CE, Weiss N, Mayaux J, Lecronier M, et al. Clinical Features and Outcomes of Human Herpesvirus-6 DNAemia in Critically Ill Patients: A Retrospective Multicenter Analysis. Clinical Infectious Diseases. 2026;82(4):698-708. doi:10.1093/cid/ciaf199

BibTeX
@article{Combet2026,
  author = {Combet, Margot and Gautheret-Dejean, Agnès and Luyt, Charles-Edouard and Weiss, Nicolas and Mayaux, Julien and Lecronier, Marie and Calligaris, Charlotte and Demeret, Sophie and Gauthier, Nicolas and Dres, Martin and Pineton de Chambrun, Marc and Pourcher, Valérie and Chommeloux, Juliette and Demoule, Alexandre and Decavèle, Maxens},
  title = {Clinical Features and Outcomes of Human Herpesvirus-6 DNAemia in Critically Ill Patients: A Retrospective Multicenter Analysis},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {82},
  number = {4},
  pages = {698--708},
  doi = {10.1093/cid/ciaf199}
}
Kostenlos starten →